It’s been a rough patch over the past two or three years for many NIH-funded research programs. This is not news. The NIH budget flatlines, combined with inflation in the cost of doing biomedical research (BRDPI is a well understood acronym by now), resulted in a budget that undoubled the doubling period. The growth in the research infrastructure that was facilitated by the doubling of the NIH budget had to be pared back. Painfully.
In many ways we are starting to partially adjust. PIs have closed or slimmed their shops. Departed all-soft-money jobs for lower profile institutions with hard money. Left for industry. Decreased the size of their labs. The NIH grant pressure has (seemingly) slackened a bit. Whether because of the reduced demand, because NIH ICs finally got their houses in order and smoothed the payout stream or because some of the 5yr commitments from the end of the doubling finally started to subside I don’t know. Things seem ever so slightly better in the past 6-9 mo.
And now, the other shoe is falling. The local Universities are going broke and putting another squeeze on the research scientists.

Read the rest of this entry »